Explore our brands

Our brands bring together the industry's most influential leaders and scientific experts, inspiring thought-provoking and insightful content that offers a unique perspective on R&D trends and challenges.
Contact

Breaking Down Silos. Connecting Expertise. Accelerating Patient Impact.

Multi-Omics Development & Applications at Precision Medicine East


, ,

The Multi-Omics Development & Applications program covers how genomic, proteomic and wider multi-omics data is generated and used in drug discovery and development. It is for multi-omics teams, spatial biology experts, translational scientists and technology providers.

Session Themes

Innovations in Spatial Multi-Omics
New spatial technologies and methods for combining molecular data with tissue architecture to reveal cellular interactions and disease mechanisms.

Multi-Omics Applications in Drug Discovery, Translational Development & the Clinic
Using integrated omics data to speed discovery, strengthen translational research, validate biomarkers and support clinical decisions.

Integrated Spatial Biology & Single Cell Analysis
Combining spatial and single-cell methods to map tissue microenvironments, cellular diversity and cell-to-cell interactions.

Featured Sessions

Mapping the Path to Clinical Implementation of Multi-Omics · Achieving Integrated Single Cell & Spatial Analysis Studies · Implementing Alternative Models in Spatial Research (panel)

Multi-omics in Boston

Building on 15 years of NextGen Omics in Boston, Multi-Omics at Precision Medicine East draws on some of America's longest-standing academic, clinical and research institutions.

With a strong emphasis on translational science and clinical validation, the program looks at how genomics, proteomics and integrated molecular profiling are shaping disease understanding, biomarker discovery and therapeutic development, with spatial biology across the agenda.

Boston Skyline

The questions shaping multi-omics in 2027

Multi-omics has always been at the heart of the Boston event.

NextGen Omics, Spatial & Data US built a community around new ways of measuring biology, and as Precision Medicine East that community now sits at the centre of a wider programme.

Advances in single-cell, spatial and multi-omics technologies are showing disease biology in more detail than ever, and AI is linking those molecular layers with imaging and clinical data. The question is how to translate these insights into better decisions: which patients will benefit, which targets to pursue and how to design more effective clinical trials.

At Precision Medicine East, the program runs alongside Biomarkers & CDx; Computational Pathology, AI & Precision Diagnostics; and AI, Data & Analysis, so omics scientists can collaborate with biomarker specialists, pathologists and data experts to advance drug development and clinical applications.

Multi-Omics & Applications Program Speakers

Who should attend

Omics Team

Translational Scientists

Bioinformaticians 

Spatial biology specialists  

Single-cell experts 

Clinical genomics teams 

Genomic biomarker researchers 

Proteomics specialists 

Technology providers 

Event Attendee Walking Happily

Featured Speakers for Precision Medicine East Multi-Omics Development & Applications

Asaf Rotem
Senior Director,
AstraZeneca
Chandra Saravanan
Director, Pathology,
Novartis Pharma
Clarence Yapp
Director of Microscopy & Computer Vision,
Harvard Medical School
Don Zack
prof,
Johns Hopkins University
Elaine Joseph
Director, Precision Medicine,
AstraZeneca
Frank Borriello
Founder & Chief Executive Officer,
Alloplex Biotherapeutics
Greg Timp
Brosey Professor of Engineering,
Notre Dame University
John Dipersio
Professor,
Washington University in St. Louis
Joyce Lo
Associate Director,
Biogen
Kisha Sivanathan
Senior Scientist,
AstraZeneca
Lee Lichtenstein
Director,
Broad Institute of MIT and Harvard
Leonard Lipovich
adjunct professor,
Kean University
Show More Speakers
Hide Speakers
Subhajyoti De
Professor,
Rutgers University
Thierry Sornasse
Senior Scientific Director,
AbbVie
Veena Kochat
Senior Research Scientist,
The University of Texas MD Anderson Cancer Center

How it connects

Multi-Omics focuses on omics technologies and their applications, and on integrating molecular layers to find new signals and develop them into precision therapeutics. Biomarkers & CDx takes those signals toward validated tests, Computational Pathology adds the tissue view, and AI, Data & Analysis provides the methods to make sense of the data. 

Frequently Asked Questions

How do we turn spatial and multi-omics data into clinical decisions?
Two dedicated tracks, Innovations in Spatial Multi-Omics and Multi-Omics Applications in Drug Discovery, Translational Development & the Clinic, cover multi-platform integration, AI-driven analytics, target validation and biomarker development. The discussion Mapping the Path to Clinical Implementation of Multi-Omics looks at what it takes to bridge discovery and the clinic.
What are the newest applications of spatial technology?
Sessions cover subcellular spatial resolution, spatial single-cell interactomics, multimodal barcoding and tissue atlas projects, and how these approaches are revealing cellular interactions and disease biology. They also look at applications in target discovery and therapeutic development, and the practicalities of scaling them.
Where is the value in integrated single-cell and spatial analysis?
Together, single-cell profiling, spatial biology, imaging and multi-omics data give a fuller picture of how cells behave in complex tissue, revealing insights single methods can miss. The Integrated Spatial Biology & Single Cell Analysis track covers patient stratification, immune regulation and target discovery.
How can multi-omics become a core part of pharma R&D?

By moving from one-off studies to scalable, integrated workflows. Sessions cover scaling spatial technologies, tools for spatial samples, integrating platforms, and combining AI with organoid and foundation models, plus how spatial, single-cell and omics data can feed target validation and biomarker development.

When and where is the Multi-omics program at Precision Medicine East?
March 23–24, 2027, at the Sheraton Boston Hotel. Session times will be on the agenda.

Be part of the conversations shaping
the future of medicine.


, ,

Spatial Multi-Omics 2026 Agenda at a Glance

DAY ONE 

Track 2: Emerging Multi-Omics Platforms and Applications: Genomics & Transcriptomics 
Track 3: Spatial Biology for Therapeutic Discovery & Development (Oncology & Immunology) 

DAY TWO 

Track 1: Emerging Multi-Omics Platforms and Applications: Proteomics, Epigenomics & Metabolomics 
Track 2: Spatial Biology for Therapeutic Discovery & Development
NGOUS Conference Brochure

Decision 1

Sentence describing Decision 1

Decision 2

Sentence describing Decision 2